Expression of Interest









Key Dates

April 2011
Registration open

Early December 2011
Call for Late Breaking Abstracts

31 January 2012
Early Bird Registration Deadline

17 February 2012
Author registration deadline

25 - 29 March 2012
Symposium dates

Hosted By

The Australian Atherosclerosis Society

Australian Atherosclerosis Society

 

 

Program Focus and Highlights

Click here to view Preliminary Program

 

Program Focus And Highlights

The key aim of ISA2012 is to provide a comprehensive, state-of-the-art overview of the current understanding of the origins, progression and prevention of atherosclerosis.  

The ISA2012 Scientific Program Committee has developed an informative program which will focus on recent clinical and scientific advances in key and emerging areas of atherosclerosis including:

  • Atherosclerosis and the immune system 
  • Diabetes, insulin resistance and atherosclerosis 
  • Epidemiology and the emergence of atherosclerosis in developing countries 
  • Genetic and genomic approaches for identifying new therapeutic targets and risk factors 
  • Gene therapy and atherosclerosis 
  • HDL function and therapeutic strategies for raising HDL levels 
  • Imaging in atherosclerosis 
  • Mechanistic aspects of atherosclerosis 
  • New insights into lipoprotein metabolism 
  • New risk factors and biomarkers in atherosclerosis: lipidomic and proteomic approaches 
  • New therapeutic approaches for treating atherosclerosis 
  • Pharmacogenomics of atherosclerotic disease 
  • Recent advances in nutrition, nutrigenomics and nutraceuticals 
  • Vascular biology of atherosclereosis 
  • Visceral obesity, metabolic syndrome and atherosclerosis 

Scope Of The Symposium

The symposium program has been developed with the assistance of members of local and international program committees. These members have extensive expertise in a wide range of atherosclerosis-related topics, ranging from epidemiology and clinical research through to vascular biology and lipoprotein metabolism. Keynote and plenary presentations on novel approaches for identifying and treating cardiovascular disease, recent advances in our understanding of cholesterol transport pathways, nutrition, biomarker identification, as well as population studies and systems biology will be delivered. Obesity and diabetes will be just two of the recurring themes that will be discussed in presentations throughout the meeting. 

In addition to offering a wide-ranging program, the meeting will provide opportunities for young investigators to present their latest work during the poster sessions, the mini-oral poster sessions and the e-poster sessions. Young investigators will also be eligible for a number of awards based on scientific merit. Travel awards are available and a special young investigator social event is planned.

The symposium will feature something for everyone, from the practising clinician, to the clinical researcher through to basic scientists studying the biology of different aspects of cardiovascular diseases. Given the speed with which the entire field is evolving, and given the increased cardiovascular risk associated with a number of pathologies that are currently reaching epidemic proportions, the broad scope of this meeting will provide ample opportunities for everyone to expand their current knowledge base.

Local Scientific Program Committee

  • Prof Kerry-Anne Rye
  • Prof Anushka Patel
  • David Celermajer
  • A/Prof Dmitri Sviridov
  • Prof Gerald Watts
  • Prof Leonard Kritharides
  • Prof Karlheinz Peter
  • Prof Mark Cooper
  • Prof Phillip Barter
  • Prof Peter Clifton
  • Prof Paul Nestel
  • Prof Wendy Jessup
  • A/Prof Terri Allen
  • Prof Karin Jandeleit-Dahm
  • A/Prof Peter Meikle
  • Dr Judy De Haan

IAS Program Committee

  • Prof Kerry-Anne Rye (Australia)
  • Dr Emilio H. Moriguchi (Brazil)
  • Dr Peter Libby (USA)
  • Dr John J.P. Kastelein (The Netherlands)